Two newly published reports available on http://www.free-research.com provide detailed guidance on the lucrative Chinese pharmaceutical market.
UK (PRWEB) February 3, 2008 -- China possesses one fifth of the world's population and has one of the largest drug markets in the world. In 2006, the Chinese pharmaceutical market reached $12 billion dollars, a four-fold increase over the 1998 market value. A series of factors, such as an increasingly aging population, accelerating growth of the urban population as well as expansion of healthcare covering urban and rural areas, will grow the Chinese drug market by 20-25 percent per annum over the next five years. China is expected to become the fifth largest drug market in the world by 2010.
As China joins the World Trade Organization and integrates more completely into the global economy, it will further open the door to a lucrative drug market for overseas pharmaceutical companies. However, the Chinese environment for the protection of intellectual property is complex. Locally produced generics and copy products currently dominate the market. It is estimated that about 97% of drugs produced by local companies are generics or counterfeits.
In order to enter such a lucrative market, pharmaceutical companies need to understand how to file applications for imported drug registration with Chinese authorities. The application and approval process is complex and regulations are variable and lack transparency. Furthermore, facing such a complex market environment, pharmaceutical companies will have an understandable fear that their imported drugs and pharmaceuticals produced in China will be copied; thereby infringing their intellectual property.
Why did Eli Lilly & Company fail in its litigation of patent infringement dispute case in China? Why can Pfizer win in an administrative proceeding against the Patent Reexamination Board of the China State Intellectual Property Office for its Viagra patent? Knowledge of the Chinese regulatory regime is paramount in such a lucrative yet complex market. Two newly published reports available on http://www.free-research.com provide detailed guidance on the lucrative Chinese pharmaceutical market.
China Guidebook for Pharmaceutical Patent Protection 2007 is an essential resource for pharmaceutical companies seeking to achieve a successful patent protection of their IP in China. The report provides regulatory guidance and case studies of patent infringements in China. Further details can be found at: http://www.free-research.com/Summary-Market-Report/China-Guidebook-for-Pharmaceutical-Patent-Protection-2007-24449.asp
China Pharmaceutical Guidebook - Latest Chinese Regulations for Imported Drug Registration provides pharmaceutical manufacturers guidance on achieving a successful application and approval for their imported drug registration. Further details can be found at:
http://www.free-research.com/Summary-Market-Report/China-Pharmaceutical-Guidebook-Latest-Chinese-Regulations-for-Imported-Drug-Registration-24448.asp
For more details on these these reports and other market research reports, please visit http://www.free-research.com. Free-Research.com is the world's largest web resource of both free and paid reports, covering 27 industry sectors globally. Free-Research.com provides the widest choice to market research buyers worldwide.
Source: PRWeb: Legal / Law
See Also
No comments:
Post a Comment